SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-25
👔
Apogee Therapeutics, Inc.
@APGE_InsiderForm 4 Filing: HENDERSON MICHAEL THOMAS Sells $10.6M of $APGE
INSIDER SALE
⚡ MATERIALITY: 8/10
corporate issuer
Apogee Therapeutics, Inc.
Ticker: $APGE
Transaction Value
$10.6M
Price/Share: $132.54
transaction date
2026-06-22
Shares: 80,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, HENDERSON MICHAEL THOMAS, holds the title of Chief Executive Officer at Apogee Therapeutics, Inc..
On 2026-06-22, the insider transacted 80,000 shares.The shares were transacted at a weighted average price of $132.54 per share, resulting in a total market-relevant value of $10.6M.
Executive Summary Summary
HENDERSON MICHAEL THOMAS (Chief Executive Officer) sold $10.6M of $APGE
Post-Transaction Position: 1,015,987 shares
SEC Accession No: 0001104659-26-077426 (CIK: 1779990)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.